IGF2BP2 and pancreatic adenocarcinoma: In GEPIA2, we found the higher IGF2BP2 expression was significantly associated with poor prognosis of most cancers, such as BLCA, GBM, HNSC, KIRC, LGG, LUAD, PAAD, SARC (Figure 11B).